Kymera Therapeutics
KYMR
#1949
Rank
C$14.11 B
Marketcap
C$165.34
Share price
-3.42%
Change (1 day)
77.55%
Change (1 year)

EPS for Kymera Therapeutics (KYMR)

EPS in 2026 (TTM): C-$5.08

According to Kymera Therapeutics's latest financial reports the company's current EPS (TTM) is C-$5.19. In 2025 the company made an earnings per share (EPS) of C-$5.28 a decrease over its 2024 EPS that were of C-$4.26.

EPS history for Kymera Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$5.08-3.82%
2025C-$5.2823.91%
2024C-$4.2617.86%
2023C-$3.61-12.5%
2022C-$4.1339.81%
2021C-$2.9522.84%
2020C-$2.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94-62.71%๐Ÿ‡บ๐Ÿ‡ธ USA